Asuhan Keperawatan pada Pasien Skizofrenia dengan Gangguan Persepsi Sensori: Halusinasi Pendengaran di Ruang Dahlia Rumah Sakit Jiwa Dr. Radjiman Wediodiningrat Lawang
DOI:
https://doi.org/10.47134/phms.v1i4.55Keywords:
Komunikasi Terapeutik, Gangguan Persepsi Sensori Halusinasi PendengaranAbstract
Halusinasi pendengaran, yang merupakan salah satu jenis halusinasi yang paling umum, sering terjadi. Masih ada banyak perawat yang tidak menggunakan komunikasi terapeutik saat memberikan perawatan kepada pasien yang mengalami halusinasi. Salah satu terapi yang dapat digunakan untuk mengendalikan halusinasi pendengaran adalah penerapan komunikasi terapeutik. Tujuan penulisan ini adalah untuk mengevaluasi efektivitas penerapan komunikasi terapeutik dalam mengontrol halusinasi pendengaran pada pasien di RSJ Lawang. Metode yang digunakan dalam penelitian ini adalah studi kasus asuhan keperawatan, yang meliputi pengkajian, perumusan diagnosa keperawatan, intervensi, implementasi, dan evaluasi. Intervensi difokuskan pada penerapan komunikasi terapeutik. Berdasarkan hasil observasi setelah penerapan komunikasi terapeutik selama 5 hari, terlihat penurunan halusinasi pendengaran pada pasien. Pemberian intervensi komunikasi terapeutik memiliki pengaruh positif terhadap penurunan halusinasi pendengaran di RSJ Lawang. Dapat disimpulkan bahwa halusinasi pendengaran dapat diidentifikasi dan dikendalikan dengan menggunakan komunikasi terapeutik, dengan menerapkan strategi pelaksanaan tertentu (SP1-SP4).
References
Afconneri, Y., Lim, K., & Erwina, I. (2020). Faktor-Faktor Kekambuhan pada Klien Skizofrenia di Poliklinik Rumah Sakit Jiwa Prof. Dr. Hb Sa’anin Padang. Jurnal Endurance: Kajian Ilmiah Problema Kesehatan, 5(2), 321–330.
Berger, M. (2018). Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology, 90, 35–42. https://doi.org/10.1016/j.psyneuen.2018.02.001
Correll, C. U. (2019). Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists. BMC Psychiatry, 19(1). https://doi.org/10.1186/s12888-019-2318-x
Ervina, I., & Hargiana, G. (2018). Aplikasi keperawatan Generalis dan Psikoreligius pada pasien pada gangguan sensori persepsi: Halusinasi penglihatan dan pendengaran. Jurnal Riset Kesehatan Nasional, 2(2), 114–123. https://doi.org/10.31219/osf.io/95nqm
Fiorillo, A. (2020). The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review. Annals of General Psychiatry, 19(1). https://doi.org/10.1186/s12991-020-00293-4
Flowers, S. A. (2019). Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia. Pharmacotherapy, 39(2), 161–170. https://doi.org/10.1002/phar.2214
Galling, B. (2018). Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia. Acta Psychiatrica Scandinavica, 137(3), 187–205. https://doi.org/10.1111/acps.12854
Iwata, Y. (2019). Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study. Biological Psychiatry, 85(7), 596–605. https://doi.org/10.1016/j.biopsych.2018.09.009
Kane, J. M. (2019). Patients with early-phase schizophrenia will accept treatment with sustained-release medication (long-acting injectable antipsychotics): Results from the recruitment phase of the PRELAPSE trial. Journal of Clinical Psychiatry, 80(3). https://doi.org/10.4088/JCP.18m12546
Keepers, G. A. (2020). The American psychiatric association practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 177(9), 868–872. https://doi.org/10.1176/appi.ajp.2020.177901
Keliat, B. A., & others. (2019). Asuhan Keperawatan Jiwa. EGC.
Kugathasan, P. (2018). Association of Secondary Preventive Cardiovascular Treatment after Myocardial Infarction with Mortality among Patients with Schizophrenia. JAMA Psychiatry, 75(12), 1261–1269. https://doi.org/10.1001/jamapsychiatry.2018.2742
Li, W. (2018). Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment. NeuroImage: Clinical, 20, 169–176. https://doi.org/10.1016/j.nicl.2018.07.008
Lorenzo, R. Di. (2019). Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: Retrospective study in a real-world clinical setting. Neuropsychiatric Disease and Treatment, 15, 183–198. https://doi.org/10.2147/NDT.S189245
Miodownik, C. (2019). Curcumin as add-on to antipsychotic treatment in patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled study. Clinical Neuropharmacology, 42(4), 117–122. https://doi.org/10.1097/WNF.0000000000000344
Pardede, J. A. (2019). Health Education of Drinking Medication Adherence on Schizophrenia Patients. Journal of Psychiatry, 2(2), 723.
Pardede, J. A., Keliat, B. A., & Yulia, I. (2020). Kepatuhan dan Komitmen Klien Skizofrenia Meningkat Setelah Diberikan Acceptance And Commitment Therapy dan Pendidikan Kesehatan Kepatuhan Minum Obat. Jurnal Keperawatan Indonesia, 18(3), 157–166.
PPNI, T. P. S. D. P. P. (2018a). Standar Diagnosis Keperawatan Indonesia Definisi dan Indikator Diagnostik.
PPNI, T. P. S. D. P. P. (2018b). Standar Intervensi Keperawatan Indonesia (Edisi 1).
PPNI, T. P. S. D. P. P. (2019). Standar Luaran Keperawatan Indonesia : Definisi dan Kriteria Hasil Keperawatan.
Putri, N. N., Nainggolan, N. L. O., Saragih, S. V. M., Novia, N., & Zega, A. (2022). Studi Kasus: Asuhan Keperawatan Jiwa Dengan Gangguan Persepsi Sensori: Halusinasi Pada Penderita Skizofrenia.
Qiao, Y. (2018). Effects of Omega-3 in the treatment of violent schizophrenia patients. Schizophrenia Research, 195, 283–285. https://doi.org/10.1016/j.schres.2017.08.026
Robertson, I. (2019). Insomnia in patients with schizophrenia: current understanding and treatment options. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 92, 235–242. https://doi.org/10.1016/j.pnpbp.2019.01.016
Shah, P. (2018). The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review. Psychiatry Research, 268, 114–122. https://doi.org/10.1016/j.psychres.2018.06.070
Taipale, H. (2020). 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry, 19(1), 61–68. https://doi.org/10.1002/wps.20699
Tarumi, R. (2020). Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology, 45(4), 632–640. https://doi.org/10.1038/s41386-019-0589-z
Thomas, M. L. (2018). Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophrenia Research, 202, 378–384. https://doi.org/10.1016/j.schres.2018.07.025
Wagner, E. (2020). Clozapine Combination and Augmentation Strategies in Patients with Schizophrenia - Recommendations from an International Expert Survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group. Schizophrenia Bulletin, 46(6), 1459–1470. https://doi.org/10.1093/schbul/sbaa060
Yu, H. (2018). Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. The Lancet Psychiatry, 5(4), 327–338. https://doi.org/10.1016/S2215-0366(18)30049-X
Yuan, X. (2018). Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia. Schizophrenia Research, 201, 299–306. https://doi.org/10.1016/j.schres.2018.05.017
Downloads
Published
How to Cite
License
Copyright (c) 2023 Health & Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
